We are live on !
Find out more
TRV GP Portfolio holdings
AUM
$18.9M
Turnover
0%
1-Year Est. Return
541.67%
This Fund
S&P 500
This Quarter Est. Return
-10.1%
1 Year Est. Return
+541.67%
3 Year Est. Return
+3,178.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$88.4M
AUM Growth
-$12.6M
(-12%)
Cap. Flow
$0
Cap. Flow % of AUM
Cap. Flow %
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
1.3
years
Top 10 Avg Time Held
1.3
years
Top 20 Avg Time Held
1.3
years
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Rhythm Pharmaceuticals
RYTM
$6.15B
| $43.6M | 49.33% |
1,981,437
| – | – |
2017 Q4
6 quarters
|
|
|
CNST
2
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $37.3M | 42.17% |
3,034,083
| – | – |
2018 Q3
3 quarters
|
|
3
DELISTED
Carisma Therapeutics
CARM
| $7.26M | 8.22% |
242,080
| – | – |
2017 Q4
6 quarters
|
|
4
Larimar Therapeutics
LRMR
$244M
| $250K | 0.28% |
17,531
| – | – |
2017 Q4
6 quarters
|
|
Similar funds
YECIP
TRV GP's Q2 2019 Portfolio in Review
As of Q2 2019, TRV GP held 4 positions worth $88.4M, down 12% from $101M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q2 2019: portfolio turnover was 0%. TRV GP opened no new positions and made no exits, leaving the 4-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- TRV GP's ten largest holdings make up 100% of its $88.4M portfolio in Q2 2019.
- TRV GP opened 0 new positions and closed 0 in Q2 2019.
- TRV GP's portfolio value fell 12% quarter-over-quarter to $88.4M.
Based on TRV GP's 13F filing for Q2 2019, filed 6 Aug 2019.